Chemomab Therapeutics Ltd. Accounts Payable, Trade, Current
Chemomab Therapeutics Ltd. (CMMB) had Accounts Payable, Trade, Current of $485.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
us-gaap:AccountsPayableTradeCurrent · last filed 2026-03-23
- 2025-12-31: Accounts Payable, Trade, Current $485.00K.
- 2025-06-30: Accounts Payable, Trade, Current $378.00K.
- 2024-12-31: Accounts Payable, Trade, Current $633.00K; Accounts Payable, Trade, Current as first filed $666.00K.
- 2024-06-30: Accounts Payable, Trade, Current $1.11M.
| Period end | Accounts Payable, Trade, Current | Accounts Payable, Trade, Current as first filed |
|---|---|---|
| 2025-12-31 | $485.00K 20-F · filed 2026-03-23 | |
| 2025-06-30 | $378.00K 6-K · filed 2025-08-14 | |
| 2024-12-31 | $633.00K 20-F · filed 2026-03-23 | $666.00K 20-F · filed 2025-04-04 |
| 2024-06-30 | $1.11M 6-K · filed 2024-08-21 | |
| 2023-12-31 | $516.00K 20-F · filed 2025-04-04 | |
| 2023-06-30 | $2.35M 6-K · filed 2023-08-14 | |
| 2023-03-31 | $2.22M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.69M 20-F · filed 2024-03-28 | |
| 2022-09-30 | $1.25M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.43M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $1.49M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.34M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $481.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $472.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $2.08M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $93.00K 10-K · filed 2022-03-30 | $678.00K 10-K · filed 2021-03-09 |
| 2020-09-30 | $482.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $974.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $602.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $875.00K 10-K · filed 2021-03-09 | |
| 2018-12-31 | $396.00K 10-K · filed 2020-03-17 |